Breadcrumb Navigation:

Home > News

News

Read the latest about multiple sclerosis: news on promising treatments, legislation affecting the lives of people with MS, updates on the Society and its functions, and people living with MS.

If you are searching by date range, select the start/end dates by using the calendar utility located to the right of the textboxes (requires JavaScript). Click on the calendar icon to launch the utility. After selecting a date, the utility will close and the date will appear in the textbox. If your browser does not support JavaScript, you can type the dates directly into the textboxes.

To reset the form, click the 'reset form' button.


TitleDate
Society-funded Study Shows Evidence of Nerve Regeneration within MS LesionsAug 19, 2008
Exploring Why Physical Activity is Reduced in People with MS: Society-funded Investigators Seek ParticipantsAug 19, 2008
FDA-Approved Label Changes Clarify Tysabri’s Indications and Should Ease Coverage by Health Plans Aug 15, 2008
Society Participates in 2008 World Stem Cell SummitAug 14, 2008
MS Trial Alert: Study of Ocrelizumab Recruiting People with Relapsing-Remitting MSAug 13, 2008
Society-funded Researchers Find Pattern of Gene Activity Associated with High Risk for MSAug 13, 2008
Data Center Chosen to Foster Research by National MS Society Pediatric Centers of ExcellenceAug 13, 2008
New Recommendations from the FDA Concerning the Monitoring of Cardiac Function in People Taking Mitoxantrone Aug 11, 2008
Two New Cases of PML Develop in People with MS Taking TysabriAug 01, 2008
MS Trial Alert - Single-Dose Experimental IV Drug “RTL1000” Recruiting MS Patients at Five Sites NationwideJul 18, 2008
Researchers Reprogram Adult Stem Cells in Mouse Brain to Become Myelin-Making CellsJul 16, 2008
Announcing New National Health Care Reform PrinciplesJul 11, 2008
Caffeine Protects Mice from MS-like Disease, But More Research Required to Translate Results to PeopleJul 09, 2008
Media Opportunity: Largest International Conference on MS Research and Treatment in 2008 to be held in Montreal, Canada, September 17-20Jul 02, 2008
Previous Report of Two Cases of Melanoma (Skin Cancer) Reported in People Taking Tysabri for MS Updated with Company RebuttalJul 02, 2008
Are You Using Complementary/Alternative Therapies? It’s Time to Talk, Says the NIHJun 27, 2008
Molecule Strikes Balance in Immune System and May Be Key to Autoimmune Attack in MSJun 19, 2008
Laquinimod Results Published: Oral Drug Reduces Disease Activity in Phase 2 StudyJun 19, 2008
MS Trial Alert: Study of Oral Teriflunomide (HMR1726) Recruiting People at High Risk for MS WorldwideJun 12, 2008
Clinical Trials in Multiple Sclerosis 2008Jun 12, 2008
Small Study Suggests High Dose Regimen of Cancer Drug Cyclophosphamide Reduces MS Disease ActivityJun 11, 2008
Serious Infections – One Fatal – Experienced by Two People Participating in Clinical Trials of FTY720 for MSJun 06, 2008
Long-Term Study Yields Clues for Predicting Future Course of MSJun 05, 2008
Society-Funded Study: Cell Transplants Lead to Neurological Recovery in Some Mice Born without MyelinJun 05, 2008
U.S. Veteran Living with MS Testifies Before CongressJun 04, 2008
Fampridine-SR Improves Walking Speed in All Types of MS in Second Phase 3 StudyJun 03, 2008
Low Dose Naltrexone UpdateJun 02, 2008
New Study Suggests Immune Genes Help Determine Sites of MS Damage and SymptomsMay 29, 2008
MS Trial Alert - Participants Sought for Two New Clinical Trials of Oral Drug BG00012 for Relapsing-Remitting MS - UPDATEDMay 21, 2008
MS Trial Alert: France: Small Study of PI-2301, Co-polymer, Recruiting People with Secondary-Progressive MS May 19, 2008
MS Trial Alert: Investigators Recruiting Participants with MS for Two Studies of AlemtuzumabMay 16, 2008
Study Highlights Need for Early Learning Intervention in Some Children with MSMay 13, 2008
National MS Society Names Congressman Russ Carnahan as Representative of the YearMay 08, 2008
National MS Society Names Richard Durbin as Senator of the YearMay 08, 2008
Prozac® Reduces MS Disease Activity, But Not Significantly, in Small StudyMay 04, 2008
Progress on Experimental Therapies for MS, and Much More, Reported at the American Academy of Neurology MeetingMay 01, 2008
MS Trial Alert: Oral Treatment (“CDP323”) Under Study in Relapsing MSApr 30, 2008
MS Trial Alert: Clinical Trial of Sex Hormone Estriol Recruiting Women with MS to Participate - UPDATEDApr 25, 2008
Change in Blood Donation Policy at American Red CrossApr 24, 2008
Dr. Stephen Hauser, Pioneer in MS Genetics, Awarded 2008 John Dystel PrizeApr 15, 2008
Disappointing Results from Trial of Rituximab in Primary-Progressive MSApr 15, 2008
Society Funds Novel Clinical Trial of Harmless Worms, Based on “Hygiene Hypothesis”Apr 11, 2008
Norwegian Researchers Confirm Higher Rates of Symptoms of Depression and Anxiety in People with MSApr 04, 2008
MS Trial Alert: Study of Long-term Safety of Tysabri® To Enroll 2500 in North AmericaApr 04, 2008
61 New Research Projects Launched Totaling $24 Million To Propel Multiple Sclerosis ResearchApr 04, 2008
MS Trial Alert - Investigators Enrolling People in UK with MS in Study of Cannabis for Neuroprotection, and in Study of Cannabis for Muscle StiffnessApr 02, 2008
Study: People with MS Who See Neurologists Are More Likely to Use MS DrugsMar 28, 2008
MS Workplace Launched To Support People Living With Multiple Sclerosis Achieve Career GoalsMar 26, 2008
Ethics of Placebos in MS Clinical Trials Reassessed in New PublicationMar 26, 2008
Investigators Explore MS Risk Conferred by Combination of Gene and VirusMar 26, 2008
Loss of Mobility Found to Impact Quality of Life and Emotional and Financial Health of Most People Living with Multiple SclerosisMar 25, 2008
Compound Protects Nerves from Injury in National MS Society-funded Study of Mice with Progressive MSMar 19, 2008
Endless Pools, Inc. and National Multiple Sclerosis Society Raise Awareness For Healthy LivingMar 11, 2008
WHAT WILL YOU DO? Join the Movement to End Multiple Sclerosis During MS Awareness Week March 10-17Mar 10, 2008
MS Trial Alert - Large Study of Oral Laquinimod Seeking ParticipantsMar 07, 2008
MS Trial Alert - Five U.S. Sites Enrolling to Evaluate Effects of Tysabri on VaccinationFeb 29, 2008
High-Tech Study of MS Brain Specimens Uncovers Hundreds of Proteins That May Offer Clues to Future Treatment ApproachesFeb 17, 2008
Study: One Course of Rituximab Reduced MS Disease Activity for 48 WeeksFeb 14, 2008
MS Trial Alert: Clinical Trial of Investigational, Once-Daily Oral FTY720 Recruiting Participants with MS across the U.S.Feb 08, 2008
Two Cases of Melanoma (Skin Cancer) Reported in People Taking Tysabri for MSFeb 07, 2008
Tysabri Label Changed To Reflect Potential Liver DamageFeb 01, 2008
Genetic Differences May Predict Response to Interferon Treatment for MS Jan 25, 2008
Tysabri Improved Quality of Life among Participants in Pivotal Clinical Trials in MSDec 21, 2007
Study Enrolling to Evaluate Effects of Tysabri on Fatigue and CognitionDec 14, 2007
Great Strides Moved MS Research Forward During 2007Dec 14, 2007
Study Suggests MS Drugs Delay Progression of Disability in Relapsing MSDec 07, 2007
Study Suggests Copaxone Treatment Reduces Risk of Developing MSDec 06, 2007
Guidelines for Administration of Human Papillomavirus (HPV) Vaccine (Gardasil®) to Multiple Sclerosis PatientsNov 30, 2007
Study Finds Evidence of Epstein-Barr Virus in Multiple Sclerosis Brain Tissues;Nov 05, 2007
Clear Channel Communications, Inc. Receives National MS Society's “Shining Star” AwardNov 03, 2007
Research Progress Reported at International ECTRIMS Meeting:Oct 30, 2007
Corporate “Stars” Gather to Shine a Light on Raising Awareness for Multiple SclerosisOct 26, 2007
Christopher & Banks: Corporate “Stars” Gather to Shine a Light on Raising Awareness for Multiple SclerosisOct 26, 2007
Deloitte Corporate “Stars” Recognized for Joining the Movement to End Multiple SclerosisOct 26, 2007
Genentech and Biogen Idec: Corporate “Stars” Recognized for Joining the Movement to End Multiple SclerosisOct 26, 2007
Microsoft: Corporate “Stars” Recognized for Joining the Movement to End Multiple SclerosisOct 26, 2007
New Survey Finds Technology Plays a Critical Role in the Lives of People with Multiple Sclerosis Yet Many Are Not Using It to Overcome Disease-Related ChallengesOct 26, 2007
Researchers Report Findings on Antibody That Stimulates Myelin RepairOct 12, 2007
Researchers Report Success Promoting Myelin Repair in Mice with MS-like DiseaseOct 05, 2007
Flu Vaccine and MSOct 01, 2007
Eye Scanning Device Detects MS Nervous System DamageSep 17, 2007
USA Today Continues “Spirit of the USA” Charity Program as Part of Newspaper's 25th Anniversary CelebrationSep 17, 2007
Researchers Report that Stopping Tysabri Increased MRI-Detected Disease Activity in Some PatientsSep 14, 2007
Small Phase 2 Study of Daclizumab Shows Benefit Alone and in Combination with InterferonAug 23, 2007
Results Published on BHT-3009, Experimental DNA Vaccine Treatment for MSAug 15, 2007
Betaseron “BENEFIT” Follow-Up Study Results Published Aug 03, 2007
International Collaborators Identify New Genetic Risk Factors for MSJul 30, 2007
Study Finds Early Sun Exposure Associated with Reduced Risk of MSJul 24, 2007
Immune System Variations May Underlie Differences in MS Between African Americans and Caucasians Jul 05, 2007
National MS Society Mourns the Loss of Beverly Sills GreenoughJul 02, 2007
Disputing Earlier Findings, New Study Reports Men and Women with MS Transmit the Disease Equally to Their ChildrenJun 29, 2007
ACTRIMS and CMSC Meetings Focus On Emerging MS Therapies and Quality of Life IssuesJun 22, 2007
People Who Develop MS in Childhood Take Longer to Develop Progressive Disability, International Study FindsJun 20, 2007
Possible Target of Immune Attack in MS and New Therapeutic Approach Identified by National MS Society-Sponsored Investigators - -- Protein produced to protect brain from harm may become targetJun 13, 2007
Positive Results Published on Testosterone for Men with MSMay 18, 2007
Progress on Experimental Therapies for MS, and Much More, Reported at the American Academy of Neurology MeetingMay 11, 2007
Genetics Consortium Finds Gene that May Protect Against MSMay 11, 2007
Dr. Howard Weiner, Pioneer in MS Immunology and Therapy, Awarded 2007 John Dystel PrizeMay 04, 2007
Is Multiple Sclerosis Increasing among Women Compared to Men?Apr 27, 2007
Landmark Compendium on Pediatric MS Published with Funding from the National MS SocietyApr 20, 2007
Society-Funded Researchers Find Cells that May Promote Myelin Repair in MSApr 20, 2007
Analysis Shows Tysabri Helps Reduce Vision Loss in Relapsing MS Apr 20, 2007
The Ethics of Placebo Controls in MS Clinical Trials - International Meeting Convened by National MS SocietyApr 06, 2007
Multiple Sclerosis Coalition EstablishedApr 01, 2007
Researchers Stop MS-like Disease in Mice by Targeting a Blood ProteinMar 30, 2007
National MS Society Selected as “Charity of Choice” by USA TODAYMar 30, 2007
Accessible Technology Can Offer Customizable Solutions to People with MSMar 19, 2007
Accessible Technology Can Offer Customizable Solutions to People with MSMar 19, 2007
Patients in Cannabis-Based Drug Trial Reported Some Benefit for Relieving Spasticity in MSMar 09, 2007
National Multiple Sclerosis Society Launches A New Movement By And For People With MSMar 05, 2007
National Multiple Sclerosis Society And Wieden+Kennedy New York Rally The Nation To Join The MovementMar 05, 2007
Nine Non-profit Organizations Partner in the i'm InitiativeMar 01, 2007
New Study in Mice May Help Explain MS Remissions During PregnancyFeb 22, 2007
Researchers Report on Follow-Up of People with “Benign” MSFeb 13, 2007
NBC's “TODAY” Show Green Room Book Auctioned to Benefit National MS Society and Move Us Toward a World Free of MSFeb 02, 2007
National MS Society Raises Concerns that Recent NIH Study Underestimates Number of People with MS in the U.S.Jan 30, 2007
Many People with MS Report Financial Strain Related to Health Care Jan 30, 2007
Study Suggests Family Members May Share Some Features of MS, But Not its SeverityJan 30, 2007
Study Refutes Prior Claim that Blood Test Can Predict Course of MSJan 26, 2007
Rare Brain Disease (PML) Developed by People Taking Rituxan® Drug Under Study for Treating Multiple SclerosisDec 19, 2006
Study Finds Vitamin D May Lower Risk for MSDec 19, 2006
2006 A Very Good Year in MS ResearchDec 08, 2006
Society-Supported Investigators Uncover Clue to MS RelapsesDec 04, 2006
Researchers Find Extensive Repair of Myelin in Brains of Some People with MSDec 01, 2006
Michael “Lenny” McKean Supports Those With MS on Celebrity Jeopardy, November 21st Nov 21, 2006
European Collaborators Identify Two Genes That May Help Confer Susceptibility to MSNov 17, 2006
Sex Hormone Trial in Women with MS Launched National MS Society’s Southern California Chapter Pledges to Raise FundsNov 10, 2006
Corporate “Stars” Gather to Shine a Light on Raising Awareness for Multiple SclerosisNov 03, 2006
FDA Expands Approval of Betaseron® to Include Those at High Risk for Developing MSOct 23, 2006
ACTRIMS Meeting Focuses On Search for Biomarkers in MSOct 20, 2006
New Study: How B Cells May Contribute to Damage of Nerve Fibers in MSOct 19, 2006
ECTRIMS Meeting Highlights Drug Trials, MS in ChildrenOct 13, 2006
Fampridine Improves Walking Speed and Leg Strength in MS, Announces Drug CompanySep 25, 2006
FDA Agrees to Fast Review for Pill Being Tested for MSSep 21, 2006
Vitamin B3 Protects Nerve Tissue from Further Damage in Mice with MSSep 21, 2006
Bill Klesse, CEO, Valero Energy Corporation, Honored By Joyce Nelson, CEO, National Multiple Sclerosis Society.Sep 19, 2006
Oral Fingolimod Reduces MS Disease ActivitySep 14, 2006
Better Communication Needed Between Physicians And Patients With Disabilities, Says Society GranteeSep 07, 2006
67 New Research Projects Launched For $26 Million To Fuel Momentum In Multiple Sclerosis ResearchSep 01, 2006
Results Reported on High-Dose Immunosuppressant for MSAug 25, 2006
Cast Of Scrubs Hit The Links On The Golf Channel's Big Break All Star ChallengeAug 22, 2006
New International “Atlas of MS” LaunchedAug 21, 2006
Results Published on Early Treatment with BetaseronAug 18, 2006
Montel Williams' Annual Show on MS Set to Re-Air September 1Aug 07, 2006
Study Suggests Tetanus Vaccination Associated with Lower Risk of Developing MSAug 02, 2006
Transmitting MS To Children: Possible Differences In Men And WomenJul 27, 2006
Maintaining the Effects of Novantrone: A Small StudyJul 25, 2006
New Findings on CopaxoneJul 20, 2006
Tysabri Approved For Marketing in European Union for the Treatment of Relapsing-Remitting MSJun 29, 2006
Researchers Restore Nerve Function in Rats Using Embryonic Stem CellsJun 22, 2006
Novel Oral Therapy Suppresses Immune Attack in MS ModelJun 15, 2006
FDA Approves Tysabri's Return To Market For Relapsing MS: Company Hopes to Make Drug Available in JulyJun 06, 2006
EARLY TREATMENT FAVORED FOR MULTIPLE SCLEROSIS: Pros and Cons Debated in Medical JournalMay 26, 2006
Update: The Use of Aimspro, or Goat Serum, in MSMay 19, 2006
National MS Society Creates New Training Program For Rehabilitation ResearchMay 19, 2006
Positive Results Reported For Oral Teriflunomide For Relapsing MSMay 12, 2006
Promising Advances in MS Research Reported at the AANApr 14, 2006
Researchers Find New Link Between Epstein-Barr Virus and MSApr 12, 2006
Small Study Shows Possible Benefit Of Testosterone Gel In Men With MSApr 04, 2006
Neurologist Awarded 2006 John Dystel Prize For Pioneering Research On Role Of Infections In Triggering MS RelapsesApr 04, 2006
FDA Makes Changes to the Labeling of Cipro® (ciprofloxacin)Apr 03, 2006
Society of FSP Partners with National MS Society Mar 14, 2006
VolunteerMatch And The National Multiple Sclerosis Society Partner To Engage Volunteers In The Fight Against MSMar 14, 2006
FDA Announced Withdrawl of Pemoline (Cylert) From the MarketOct 01, 2005
The Uses of Botulinum Toxin in Multiple SclerosisAug 01, 2005
Neutralizing AntibodiesAug 01, 2005

Back to top